Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Anemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05434000
What this trial is testing

Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community

Who this might be right for
Sickle Cell DiseaseStroke
Barau Dikko Teaching Hospital 217
Not applicableStudy completedNCT05407805
What this trial is testing

Learn About Sickle Cell Disease In Adult Patients

Who this might be right for
Sickle Cell Disease
Pfizer 98
Large-scale testing (Phase 3)Ended earlyNCT04150757
What this trial is testing

Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED

Who this might be right for
Sickle Cell DiseaseVaso-Occlusive Pain Episode in Sickle Cell DiseaseVaso-occlusive Crisis+3 more
Abigail Nixon 5
Testing effectiveness (Phase 2)UnknownNCT03719729
What this trial is testing

Rifaximin to Modify the Disease Course in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseAntibiotics
New York Medical College 20
Post-approval studies (Phase 4)UnknownNCT03171831
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

Who this might be right for
Thalassemia Major
First Affiliated Hospital of Guangxi Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00534430
What this trial is testing

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 30
Post-approval studies (Phase 4)Study completedNCT01250951
What this trial is testing

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

Who this might be right for
Myelodysplastic SyndromeThalassemia
Novartis Pharmaceuticals 111
Not applicableStudy completedNCT04584528
What this trial is testing

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseGenetic DiseaseHematologic Diseases+1 more
Duke University 279
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Not applicableActive Not RecruitingNCT05860595
What this trial is testing

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Ended earlyNCT00040456
What this trial is testing

Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate

Who this might be right for
HEMOGLOBIN SC DISEASE
Baylor College of Medicine 12
Not applicableStudy completedNCT01945073
What this trial is testing

Improving Disease Knowledge in Adolescents With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseQuality of Life
The University of The West Indies 150
Not applicableStudy completedNCT03133169
What this trial is testing

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children

Who this might be right for
Thalassemia in ChildrenPulmonary HypertensionHemolysis
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT00919503
What this trial is testing

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Who this might be right for
Non-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02065869
What this trial is testing

Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+10 more
Bellicum Pharmaceuticals 187
Testing effectiveness (Phase 2)Study completedNCT01800526
What this trial is testing

A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Bloodworks 21
Not applicableStudy completedNCT01195818
What this trial is testing

Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients

Who this might be right for
Sickle Cell Disease
Assistance Publique - Hôpitaux de Paris 53
Testing effectiveness (Phase 2)Study completedNCT06144749
What this trial is testing

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT02247843
What this trial is testing

Stem Cell Gene Therapy for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Donald B. Kohn, M.D. 4
Next Page